ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Effect of Mitral Isthmus Ablation on Recurrence Rates in High-Burden Paroxysmal Atrial Fibrillation.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Patients with high-burden paroxysmal atrial fibrillation (AF) have a higher rate of AF recurrence after catheter ablation than do those with a lower AF burden. The blockade rate of mitral isthmus (MI) ablation can contribute to the maintenance of sinus rhythm and be high based on the ethanol infusion of the vein of Marshall. MATERIAL AND METHODS Patients with high-burden paroxysmal AF who underwent PVI alone or PVI with additional MI ablation were assigned to the "2C" and "2C1L" groups, respectively, based on 2: 1 propensity score matching. The 12-month freedom from AF or atrial tachycardia was compared between the 2 groups. RESULTS The MI blockade rate was 98.0% in the 2C1L group. There was a higher incidence of first-pass isolation (94.1% vs 79.5%, P=0.034), with a comparable incidence of acute pulmonary vein reconnection (3.9% vs 4.9%, P=1.000) of left PVI circles in the 2C1L group, compared with in the 2C group. Both groups exhibited a minimal incidence of complications, with no statistically significant differences observed between them (3.9% vs 4.9%, P=1.000). During the 12-month follow-up, the 2C1L group demonstrated a lower incidence of recurrent AF, atrial flutter, and atrial tachycardia following the initial ablation procedure than did the 2C group (P=0.045). CONCLUSIONS Among patients with high-burden paroxysmal AF, the combination of PVI and MI ablation decreased the likelihood of AF recurrence, when compared with PVI alone, at 12 months after the procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.